This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, B J
Right arrow Articles by Peterson, P K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, B J
Right arrow Articles by Peterson, P K

 Previous Article  |  Next Article 

Infect Immun. 1979 December; 26(3): 1159-1163

Localization of the third component of complement on the cell wall of encapsulated Staphylococcus aureus M: implications for the mechanism of resistance to phagocytosis.

B J Wilkinson, S P Sisson, Y Kim and P K Peterson

ABSTRACT

Encapsulated Staphylococcus aureus strains are more virulent than unencapsulated staphylococci, and this phenomenon has been associated with decreased opsonization of encapsulated bacteria by normal human serum. Peptidoglycan, a major cell wall component of S. aureus, has been shown to promote opsonization of this bacterial species by certain components of the serum complement system. However, when the processes of complement activation and opsonization of encapsulated staphylococci have been studied, it has been found that encapsulated bacteria activate complement efficiently and C3 is bacteria associated, yet these organisms are not efficiently phagocytized by human polymorphonuclear leukocytes. In this study, the hypothesis was tested that opsonically active molecules are not on the true external surface of encapsulated organisms but rather are cell wall associated and thus "hidden" from human polymorphonuclear leukocytes. By using immunoelectronmicroscopy, C3 was found to be localized on the cell wall of an encapsulated S. aureus strain after incubation of the organism in normal human serum. When shrinkage of the capsule was prevented by treatment with anticapsular antibody, the C3 was again shown to be cell wall associated and located beneath the bacterial capsule. These results suggest that encapsulated S. aureus may resist phagocytosis because opsonically active C3 molecules are not exposed at the true external surface of the bacterium.


Infect Immun. 1979 December; 26(3): 1159-1163




This article has been cited by other articles:

  • Pirofski, L.-A. (2006). Of Mice and Men, Revisited: New Insights into an Ancient Molecule from Studies of Complement Activation by Cryptococcus neoformans.. Infect. Immun. 74: 3079-3084 [Full Text]  
  • Gates, M. A., Kozel, T. R. (2006). Differential Localization of Complement Component 3 within the Capsular Matrix of Cryptococcus neoformans.. Infect. Immun. 74: 3096-3106 [Abstract] [Full Text]  
  • Watts, A., Ke, D., Wang, Q., Pillay, A., Nicholson-Weller, A., Lee, J. C. (2005). Staphylococcus aureus Strains That Express Serotype 5 or Serotype 8 Capsular Polysaccharides Differ in Virulence. Infect. Immun. 73: 3502-3511 [Abstract] [Full Text]  
  • Lee, L. Y. L., Liang, X., Hook, M., Brown, E. L. (2004). Identification and Characterization of the C3 Binding Domain of the Staphylococcus aureus Extracellular Fibrinogen-binding Protein (Efb). J. Biol. Chem. 279: 50710-50716 [Abstract] [Full Text]  
  • Haziot, A., Hijiya, N., Schultz, K., Zhang, F., Gangloff, S. C., Goyert, S. M. (1999). CD14 Plays No Major Role in Shock Induced by Staphylococcus aureus but Down-Regulates TNF-{alpha} Production. J. Immunol. 162: 4801-4805 [Abstract] [Full Text]